Hallmarks of epithelial to mesenchymal transition are detectable in Crohn's disease associated intestinal fibrosis

被引:99
|
作者
Scharl, Michael [1 ,2 ]
Huber, Nicole [1 ]
Lang, Silvia [1 ]
Fuerst, Alois [3 ]
Jehle, Ekkehard [4 ]
Rogler, Gerhard [1 ,2 ]
机构
[1] Univ Zurich Hosp, Div Gastroenterol & Hepatol, Ramistr 100, CH-8091 Zurich, Switzerland
[2] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland
[3] Caritas Hosp St Josef, Dept Surg, Regensburg, Germany
[4] Oberschwaben Klin, Dept Surg, Ravensburg, Germany
来源
基金
瑞士国家科学基金会;
关键词
Crohn's disease; Epithelial-mesenchymal transition; Intestinal fibrosis;
D O I
10.1186/s40169-015-0046-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Intestinal fibrosis and subsequent stricture formation represent frequent complications of Crohn's disease (CD). In many organs, fibrosis develops as a result of epithelial to mesenchymal transition (EMT). Recent studies suggested that EMT could be involved in intestinal fibrosis as a result of chronic inflammation. Here, we investigated whether EMT might be involved in stricture formation in CD patients. Methods: Human colonic tissue specimens from fibrotic areas of 18 CD and 10 non-IBD control patients were studied. Immunohistochemical staining of CD68 (marker for monocytes/macrophages), transforming growth factor-beta(1) (TGF beta(1)), beta-catenin, SLUG, E-.cadherin, alpha-smooth muscle actin and fibroblast activation protein (FAP) were performed using standard techniques. Results: In fibrotic areas in the intestine of CD patients, a large number of CD68-positive mononuclear cells was detectable suggesting an inflammatory character of the fibrosis. We found stronger expression of TGF beta(1), the most powerful driving force for EMT, in and around the fibrotic lesions of CD patients than in non-IBD control patients. In CD patients membrane staining of beta-catenin was generally weaker than in control patients and more cells featured nuclear staining indicating transcriptionally active beta-catenin, in fibrotic areas. In these regions we also detected nuclear localisation of the transcription factor, SLUG, which has also been implicated in EMT pathogenesis. Adjacent to the fibrotic tissue regions, we observed high levels of FAP, a marker of reactive fibroblasts. Conclusions: We demonstrate the presence of EMT-associated molecules in fibrotic lesions of CD patients. These findings support the hypothesis that EMT might play a role for the development of CD-associated intestinal fibrosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Intestinal Fibrosis in Crohn's Disease: Medical Treatment or Surgery?
    Spinelli, Antonino
    Correale, Carmen
    Szabo, Hajnalka
    Montorsi, Marco
    CURRENT DRUG TARGETS, 2010, 11 (02) : 242 - 248
  • [32] Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease
    Watanabe, Daisuke
    Kamada, Nobuhiko
    FRONTIERS IN MEDICINE, 2022, 9
  • [33] Lipids drive myofibroblast activation and the epithelial-mesenchymal transition process in Crohn's Disease.
    Rizzo, G.
    Wozny, M.
    Chavez, S. E. Pineda
    Mori, G.
    Linares, A. Carriles
    Morosi, L.
    Martano, G.
    Ghisletti, S. M. L.
    Gandolfi, F.
    Vallelonga, V.
    Loy, L.
    Bezzio, C.
    Spaggiari, P.
    Dal Buono, A.
    Gabbiadini, R.
    Carvello, M.
    Spinelli, A.
    Repici, A.
    Armuzzi, A.
    Vetrano, S.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I237 - I237
  • [34] A NOVEL ORALLY ACTIVE METABOLITE INHIBITS CROHN'S DISEASE-ASSOCIATED INTESTINAL FIBROSIS
    Xie, Ying
    Fontenot, Lindsey
    Koon, Hon Wai
    GASTROENTEROLOGY, 2021, 160 (06) : S77 - S77
  • [35] A NOVEL ORALLY ACTIVE METABOLITE REVERSES CROHN'S DISEASE-ASSOCIATED INTESTINAL FIBROSIS
    Koon, Hon Wai
    GASTROENTEROLOGY, 2022, 162 (03) : S61 - S62
  • [37] Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal Transition
    Xu, Su
    Jiang, Bin
    Wang, Hui
    Shen, Cunsi
    Chen, Hao
    Zeng, Li
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2017, 2017
  • [38] LYSIL OXYDASE INHIBITOR AMELIORATES THE INTESTINAL FIBROSIS: NOVEL TREATMENT FOR INTESTINAL FIBROSIS OF CROHN'S DISEASE
    Mizushima, Ichiro
    Tsunoda, Junya
    Takada, Yoshiaki
    Hagihara, Yuya
    Ishihara, Rino
    Sugimoto, Shinya
    Sato, Toshiro
    Mikami, Yohei
    Kanai, Takanori
    GASTROENTEROLOGY, 2024, 166 (05) : S1276 - S1276
  • [39] Is perianal Crohn's disease associated with intestinal fistulization?
    Sachar, DB
    Bodian, CA
    Goldstein, ES
    Present, DH
    Bayless, TM
    Picco, M
    van Hogezand, RA
    Annese, V
    Schneider, J
    Korelitz, BI
    Cosnes, J
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (07): : 1547 - 1549
  • [40] Primary intestinal lymphoma associated with Crohn's disease
    Iribarren-Marin, Maria A.
    Gonzalez-Martin, Raquel
    Aguilar-Garcia, Jesus
    Martinez-Polanco, Cristina
    Perez-Vega, Herminia
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2011, 103 (12) : 662 - 663